Tri Liqui News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Tris Pharma, Inc. (Tris) announced today that the U.S. Food and Drug Administration has approved Dyanavel XR (amphetamine), extended release.

Tri liquiJames hackworthAndrewj cutlerTris pharma incPrnewswire tris pharma incDrug administrationNeuroscience education instituteTris branded products divisionAttention deficit hyperactivity disorderPermanent product measurePerformance totalClinical associate professorTris branded productsFull prescribing informationBoxed warningNew jersey based